Lindsay A. Md Rosenwald - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Lindsay A. Md Rosenwald has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Lindsay A. Md Rosenwald serves as Director of Journey Medical Corp (DERM). Rosenwald has also held reporting roles at Fortress Biotech, Inc. (FBIO) and Checkpoint Therapeutics, Inc. (CKPT). Rosenwald has reported 5 insider filings with the SEC since 2024. The most recent filing was in June 2026.
| Role | Director |
|---|---|
| Notability | 26/100 |
Board memberships
- Journey Medical Corp
- Fortress Biotech, Inc.
- Checkpoint Therapeutics, Inc.
Reported roles
- Director
- Director
Trading Pattern
InsiderAlpha's records for Lindsay A. Md Rosenwald go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Lindsay A. Md Rosenwald has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director at Journey Medical Corp (DERM) - 3 filings, 2025 to 2026
- PRESIDENT, CEO & CHAIRMAN at Fortress Biotech, Inc. (FBIO) - 1 filing, 2026
- Director at Checkpoint Therapeutics, Inc. (CKPT) - 1 filing, 2024
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-26 | DERM | Journey Medical Corp | A - Grant or award | 10.0K | $0.00 | |
| 2026-03-20 | FBIO | Fortress Biotech, Inc. | A - Grant or award | 475.4K | $0.00 | |
| 2025-08-05 | DERM | Journey Medical Corp | A - Grant or award | 50.0K | $0.00 | |
| 2025-06-25 | DERM | Journey Medical Corp | A - Grant or award | 7.2K | $0.00 | |
| 2024-12-17 | CKPT | Checkpoint Therapeutics, Inc. | A - Grant or award | 12.6K | $0.00 |
Companies - Last 90 Days
- Journey Medical Corp (DERM) - 1 filing, last 2026-06-26
Most Active Insiders Right Now
Lindsay A. Md Rosenwald has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Adam C. Lipson
- Brian Guan-Chyun Liu
- Nicholas Reyland Liuzza Jr.
- David M. Lobach Jr.
- 7. Cooperative Ua Lsp
- Brandon Lutnick
- Lynrock Lake LP
- Lynx1 Capital Management LP
Frequently Asked Questions
Who is Lindsay A. Md Rosenwald?
Lindsay A. Md Rosenwald serves as Director of Journey Medical Corp (DERM). Rosenwald has also held reporting roles at Fortress Biotech, Inc. (FBIO) and Checkpoint Therapeutics, Inc. (CKPT). Rosenwald has reported 5 insider filings with the SEC since 2024. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Lindsay A. Md Rosenwald submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Lindsay A. Md Rosenwald's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Lindsay A. Md Rosenwald profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.